Effectiveness, safety and costs of thromboembolic prevention in patients with non-valvular atrial fibrillation: phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database.
Giner-Soriano, Maria
Effectiveness, safety and costs of thromboembolic prevention in patients with non-valvular atrial fibrillation: phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database. [electronic resource] - BMJ open Jan 2016 - e010144 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Observational Study
2044-6055
10.1136/bmjopen-2015-010144 doi
Aged
Atrial Fibrillation--complications
Clinical Protocols
Drug Therapy, Combination
Electronic Health Records
Female
Hemorrhage--chemically induced
Humans
Male
Platelet Aggregation Inhibitors--therapeutic use
Stroke--prevention & control
Thromboembolism--prevention & control
Treatment Outcome
Vitamin K--antagonists & inhibitors
Effectiveness, safety and costs of thromboembolic prevention in patients with non-valvular atrial fibrillation: phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database. [electronic resource] - BMJ open Jan 2016 - e010144 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Observational Study
2044-6055
10.1136/bmjopen-2015-010144 doi
Aged
Atrial Fibrillation--complications
Clinical Protocols
Drug Therapy, Combination
Electronic Health Records
Female
Hemorrhage--chemically induced
Humans
Male
Platelet Aggregation Inhibitors--therapeutic use
Stroke--prevention & control
Thromboembolism--prevention & control
Treatment Outcome
Vitamin K--antagonists & inhibitors